10
http://www.thedailystar.net/supplements/24th-anniversary-the-daily- star-part-1/new-paradigm-global-generic-medicines-73290 Bangladesh has all the potentials to become a new paradigm for global generic medicines. With a population of 156.66 million, the country's social development indicators are very promising. Bangladesh is enjoying a consistent GDP growth of more than 6 percent over the last 10 years. Commendable progress has been made in areas like annual GDP growth, per capita GDP, population growth, literacy rate etc. The country's balance of payment (export plus foreign remittance minus import) is consistently increasing. Renowned global investment analysts like JP Morgan, Goldman Sachs, Investors Chronicle have highly rated Bangladesh as an attractive investment destination. Outgoing US Ambassador to Bangladesh Dan W Mozena specially focused on the potential of pharmaceutical sector along with the RMG, leather, IT sectors. He said that the Bangladeshi pharmaceutical companies will have a huge market in the USA. Bangladeshi pharmaceutical companies are in the process of getting approval from the US-FDA. Within two to three decades the Pharmaceutical sector has made a complete turnaround from an import dependent industry to almost self-sufficiency. There are about 270 licensed pharmaceutical manufacturers in the country of which over 198 companies are in operation. Domestic manufacture accounts for 97percent of the drug sales in the local market while the remaining three percent is imported. Pharma sector is now considered technologically the most developed manufacturing industrial sector in Bangladesh and the second highest contributor to the national exchequer.

http7

Embed Size (px)

DESCRIPTION

value: the four cornerstone website

Citation preview

http://www.thedailystar.net/supplements/24th-anniversary-the-daily-star-part-1/new-paradigm-global-generic-medicines-73290angladesh has all the potentials to become a new paradigm "or global generic medicines. #ith a population o" 1$%.%% million& the country's social development indicators are very promising. angladesh is en(oying a consistent )*+ growth o" more than % percent over the last 10 years. ,ommendable progress has been made in areas li-e annual )*+ growth& per capita )*+& population growth& literacy rate etc. .he country's balance o" payment /e0port plus "oreign remittance minus import1 is consistently increasing. 2enowned global investment analysts li-e 3+ 4organ& )oldman 5achs& 6nvestors ,hronicle have highly rated angladesh as an attractive investment destination. 7utgoing 85 9mbassador to angladesh *an # 4o:ena specially "ocused on the potential o" pharmaceutical sector along with the 24)& leather& 6. sectors. ;e said that the angladeshi pharmaceutical companies will have a huge mar-et in the 859. angladeshi pharmaceutical companies are in the process o" getting approval "romthe 85- companies are in operation. *omestic manu"acture accounts "or 97percent o" the drug sales in the local mar-et while the remaining three percent is imported. +harma sector is now considered technologically the most developed manu"acturing industrial sector inangladesh and the second highest contributor to the national e0che?uer. .he local mar-et is about 85* 1.$1 billion and is the largest white collar employment sector.+harma e0ports have risen to around 85* $9.>2 million in @scal 2012-13 with ,9)2 o" 2$.$ percent "or the last @ve years. .here is a growing demand "or angladeshi medicines in 5outheast 9sia& 9sia +aci@c and 9"rica. 9t present around 30 angladeshi pharmaceutical companies are e0porting medicines to 90 countries in Aurope& 9sia& 9"rica and Batin 9merica. angladeshi companies are now "ocusing on developed mar-ets such as Aurope& 9ustralia& Batin 9merica and the )ul" countries. .op companies have already started e0porting to stringently regulated mar-ets and are getting very good responses. 6n the ne0t couple o" years& the angladesh pharma industry will grow stronger and playa ma(or role in the global generic mar-et which is now 85* 300 illion with a ,9)2 o" 9.3 percent. #ithin 2017& there will be patent e0piry o" some bloc-buster drugs and as aresult the global generic mar-et will be more than 85* 400 billion. 9round >0 percent o"the world's population consumes generic products. 4oreover& in many countries& new government provisions& changing demographics and the li"estyle will continue to increase the use o" global generic medicines. 6ndia and ,hina are the ma(or players in the world generic mar-et. 9ccording to industry e0perts& most o" the developed countries are loo-ing "or another dependable alternative source rather than 6ndia and ,hina and this is where angladeshcan strongly position itsel" as the most suitable and competitive candidate to capture substantial mar-et share o" global generic medicine. 9s a result& angladesh can emerge as a potential global generic player.#ith this ob(ective in mind& in the last couple o" years& angladeshi pharmaceuticals companies made huge investments /more than 85* $00 million1 "or "acility e0pansion and product development. .he country is now capable o" producing high-tech biosimilar products such as erythropoietin& eno0aparin& insulin&etc. and sterile products li-e BC+ and 5C+& pre@lled syringe& "ree:e-dried products& 4*6 /4etered *ose 6nhaler1& hormone and steroid products in their state-o"-the-art manu"acturing "acilities. .he country has a large pool o" highly-s-illed human resource both at home and abroad who are capable to trans"orm angladesh to a ma(or global source o" aDordable generic medicines and vaccines. y this time& a good number o" pharmaceutical companies have obtained certi@cations "rom the 8E& the Auropean 8nion& 9ustralia& the )ul" countries and other regulatory authorities. #ithin a couple o" years& more angladeshi companies will receive certi@cation "rom these authorities. 9t present 3&%00 angladeshi brands are already internationally registered and among them 100 are in regulated mar-ets.fficer an0 =resi0ent6 sai06 ?We are "er7 eCcite0 to announce t;e consummation of t;e CareFusion acquisition6 as it represents a maDor milestone in BDBs ''),7ear ;istor7 T;is acquisition si